Advertisement

A Transverse and Longitudinal Study of Pancreatic Function and Glucose Tolerance in Thalassemic Patients

  • L. Cavallo
  • F. Trentadue
  • S. Liuzzi
  • T. Giobbe
  • R. Leuzzi
  • V. Sabato
  • D. De Mattia
  • F. Schettini

Abstract

Poly transfused thalassemia major (Th) patients show a high prevalence (frequently reported > 50%) of impairment of β-pancreatic function (PF) and of overt diabetes mellitus (10–25%). The impairment of liver function, the hyperinsulinemia following insulin resistance, the hyperglucagonemia, the β-pancreas exhaustion, the genetic predisposition, and the increased frequency of viral infections could play a role in the pathogenesis of the PF derangement [1–7]. The prevalence of diabetes mellitus has been reported to be lower in regularly (16%) than in irregularly (23%) ironchelated Th patients [7]. In this retrospective transverse and longitudinal study we have evaluated the effect of the improvement of chelation and transfusion protocols on the prevalence of PF and of impaired glucose tolerance (GT) in Th patients.

Keywords

Oral Glucose Tolerance Test Ferritin Level Pancreatic Function Chelation Therapy Thalassemic Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lassman MN, Genel M, Wise JK, Hendler R, Felig P (1974) Carbohydrate homeostasis and pancreatic islet cell function in thalassemia. Ann intern Med 80: 65–69PubMedGoogle Scholar
  2. 2.
    Costin G, Kogut MD, Hyman CB, Ortega JA (1977) Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major. Diabetes 26: 230–240PubMedCrossRefGoogle Scholar
  3. 3.
    Zuppinger K, Molinari B, Hirt A, Imbach P, Gugler E, Tonz O, Zurbrugg RP (1979) Increased risk of diabetes mellitus in beta-thalassemia major due to iron overload. Helv Pediatr Acta 34: 197–207Google Scholar
  4. 4.
    Capra L, Atti G, De Sanctis V, Candini G (1983) Glucose tolerance and chelation therapy in patients with thalassemia major. Haematologica (Pavia) 1: 63–67Google Scholar
  5. 5.
    Cavallo L, Acquafredda A, Bratta P, Schettini F (1985) Alterazioni della tolleranza glicidica edella funzione β-pancreatica in thalassemici major politrasfusi clinicamente prepuberi. Haematologica (Pavia) [Suppl] 1: 121–122Google Scholar
  6. 6.
    Livadas DP, Economou E, Sofroniadou K, Fotiadou-Pappa H, Van Melle GD, Temler E, Felber JP (1987) A study of beta-cell function after glucagon stimulation in thalassemia major treated by high transfusion program. Clin Endocrinol (Oxf) 27: 485–490CrossRefGoogle Scholar
  7. 7.
    De Sanctis V, Zurlo MG, Senesi E, Boffa C, Cavallo L, Di Gregorio F (1988) Insulin-dependent diabetes mellitus in thalassemia. Arch Dis Child 63: 58–62PubMedCrossRefGoogle Scholar
  8. 8.
    Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA, Tamborlane WV (1988) Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion N Engl J Med 318: 809–814Google Scholar
  9. 9.
    Jones TW, Boulware SD, Caprio S, Merkel P, Amiel SA, Pearson HA, Aherwin RS, Tamborlane WV (1993) Correction of hyperinsulinemia by glyburide treatment in nondiabetic patients with thalassemia major. Pediatr Res 33: 497–500PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • L. Cavallo
  • F. Trentadue
  • S. Liuzzi
  • T. Giobbe
  • R. Leuzzi
  • V. Sabato
  • D. De Mattia
  • F. Schettini

There are no affiliations available

Personalised recommendations